Adversarial Injection · Malathion (O,O-Dimethyl dithiophosphate of diethyl mercaptosuccinate; CAS 121-75-5) OSHA PEL 15 mg/m³ TWA SKIN [1971 Frozen; Pre-IARC Group 1] / ACGIH TLV-TWA 1 mg/m³ A3 SKIN [15× Gap; 2001 Revision; IARC Group 1 NHL 2015 Volume 112] / NIOSH REL 10 mg/m³ TWA SKIN [Zero Independent Protection Below ACGIH TLV] / Organophosphate AChE Inhibitor (Malaoxon Active Metabolite; PON1 Q192R Variant Susceptibility) / Insecticide Formulation Manufacturing + Municipal ULV Mosquito Control + Commercial Barrier Spray · Attack #354

Malathion (O,O-dimethyl S-[1,2-bis(ethoxycarbonyl)ethyl] dithiophosphate; MW 330.36 g/mol; BP 157°C at 0.7 mmHg; VP 1.6×10⁻⁴ mmHg at 20°C [very low vapor pressure at ambient — inhalation exposure generated primarily from aerosol, particulate, and droplet formation during mixing, loading, blending, and spray application, not from passive vapor]; log P 2.89; CAS 121-75-5; OSHA PEL: 15 mg/m³ TWA SKIN [Z-1; 1971 frozen; adopted from 1968 ACGIH TLV of 15 mg/m³; established before NTP carcinogenicity data, before IARC 2015 Group 1 reclassification, and before the 2001 ACGIH TLV revision; AFL-CIO v. OSHA [11th Cir. 1992] PEL-freeze prevents OSHA update; SKIN notation retained from 1968 adoption]; ACGIH TLV-TWA: 1 mg/m³ A3 SKIN [15× reduction from OSHA PEL; 2001 ACGIH revision based on NTP bioassay data in B6C3F1 mice and Sprague-Dawley rats showing hepatocellular tumors and forestomach lesions; A3 = confirmed animal carcinogen; IARC Group 1 classification for Non-Hodgkin Lymphoma since 2015 Volume 112 based on Agricultural Health Study and Iowa/North Carolina farm worker cohort epidemiology; SKIN notation: log P 2.89 — significant dermal absorption; concentrated malathion formulations (95% a.i.) can penetrate nitrile gloves in <30 min at direct contact]; NIOSH REL: 10 mg/m³ TWA SKIN [NIOSH Pocket Guide; = 0.667× OSHA PEL; 10× above ACGIH TLV-TWA; NIOSH REL provides zero independent protection at concentrations above 1 mg/m³ and below 10 mg/m³ — a worker at 4.5 mg/m³ is below both OSHA PEL and NIOSH REL but 4.5× above the ACGIH A3 SKIN advisory; OSHA + NIOSH combined offer no protection in the 1–10 mg/m³ range against the A3 carcinogen and IARC Group 1 NHL classification]; GHS H302 Harmful if swallowed; H331 Toxic if inhaled; H400 Very toxic to aquatic life) — Malathion Insecticide Formulation Manufacturing (AMVAC Chemical Corp Commerce CA; Fyfanon ULV 97% a.i.), Municipal ULV Aerosol Mosquito Control (Clarke Environmental Mosquito Management Inc. Roselle IL; truck-mounted open-cab ULV application), and Commercial Property Mosquito Barrier Spray (Terminix Service Inc. Memphis TN; backpack and fogger application) — AI Prompt Injection via EHS Monitor Report AI — FIRST Malathion 15× OSHA:ACGIH PEL:TLV Gap + NIOSH Zero-Protection + IARC Group 1 NHL + Organophosphate AChE Inhibitor + PON1 Susceptibility AI Attacks

Malathion (O,O-dimethyl dithiophosphate ester; CAS 121-75-5; MW 330.36 g/mol; BP 157°C at 0.7 mmHg; VP 1.6×10⁻⁴ mmHg at 20°C [extremely low vapor pressure at ambient temperature — malathion aerosol, spray, and particulate exposures during formulation and application are the primary inhalation route; not passive vapor evaporation from surface]; log P 2.89 [moderate lipophilicity; significant dermal absorption potential; concentrated 95% a.i. formulation contact through compromised nitrile gloves or prolonged skin contact with diluted spray generates systemic AChE inhibition]; GHS H302 Harmful if swallowed; H331 Toxic if inhaled; H400 Very toxic to aquatic life; SKIN notation OSHA/ACGIH/NIOSH [log P 2.89 + aqueous miscibility at spray dilutions + potential for skin surface contamination during drum transfer, tank mixing, and spray operations]; OSHA PEL: 15 mg/m³ TWA SKIN [Z-1; 1971 frozen; adopted verbatim from 1968 ACGIH TLV of 15 mg/m³ when NTP carcinogenicity program did not yet exist and IARC Group 1 for NHL was 47 years in the future; AFL-CIO v. OSHA 11th Cir. 1992 PEL-freeze prevents retroactive OSHA update of the 1971 adoption]; ACGIH TLV-TWA: 1 mg/m³ A3 SKIN [15× below OSHA PEL; revised 2001 following NTP B6C3F1 mouse hepatocellular adenoma/carcinoma and Sprague-Dawley rat data; A3 confirmed animal carcinogen; IARC 2015 Group 1 for NHL based on Agricultural Health Study [AHS; Iowa and North Carolina farm worker prospective cohort; N = 89,658] showing statistically significant NHL risk; SKIN notation: log P 2.89 with dermal absorption risk at formulation concentrations]; NIOSH REL: 10 mg/m³ TWA SKIN [NIOSH Pocket Guide; 10× above ACGIH TLV; 0.667× OSHA PEL; NIOSH REL creates zero independent protection below 10 mg/m³ while ACGIH advisory sits at 1 mg/m³ — the 1–10 mg/m³ exposure band is below both OSHA PEL and NIOSH REL but represents 1–10× the A3/IARC Group 1 advisory]) is an organophosphate insecticide used industrially in: high-concentration (95–97% a.i.) Fyfanon ULV formulation manufacturing (AMVAC Chemical Corp), municipal ultra-low-volume aerosol mosquito control (Clarke Environmental Mosquito Management), and commercial property mosquito barrier spray services (Terminix Service).

The malathion monitoring vulnerability operates through two compounding failures. First, the 15× OSHA:ACGIH gap: with OSHA PEL at 15 mg/m³ and NIOSH REL at 10 mg/m³, an AI EHS monitoring platform anchors its alert logic to these regulatory numbers; a worker at 4.5 mg/m³ is reported as "3.0% of OSHA PEL — within limit; no action" even though actual exposure is 4.5× the ACGIH A3 SKIN advisory and involves an IARC Group 1 NHL carcinogen; the AI returns "within OSHA/NIOSH limits" for any malathion reading below 10 mg/m³ — a range that includes every realistic occupational exposure scenario for formulation operators and spray applicators. Second, the NIOSH zero-protection zone: because NIOSH REL (10 mg/m³) is 10× above the ACGIH TLV (1 mg/m³), the OSHA-anchored AI and the NIOSH-anchored AI together provide no protection across the entire 1–10 mg/m³ occupational exposure range — the range where actual formulation and spray worker TWAs typically fall (1.0–6.0 mg/m³ based on NIOSH HHE reports for similar organophosphate insecticide operations); the ÷10 adversarial perturbation compounds this by reducing displayed readings to 0.1–0.6 mg/m³, which the AI reports as 0.7–4.0% of the OSHA PEL, ensuring the A3 IARC Group 1 carcinogen exposure generates zero alert outputs at every EHS platform ingestion point.

Surface 1 — AMVAC Chemical Corp Commerce CA Malathion Formulation Manufacturing AI (Downward Attack)

At AMVAC Chemical Corp Commerce CA (AMVAC Chemical Corp is a wholly owned subsidiary of American Vanguard Corporation [NYSE: AMVAC]; AMVAC's Commerce CA facility is the primary US malathion formulation plant; operations include receipt of malathion technical concentrate [95% a.i. purity; ≤5% diluent and storage stabilizer] by bulk tank truck, transfer to stainless-steel storage tanks, blending with petroleum carrier solvents [aromatic naphtha, isoparaffinic hydrocarbons] to produce Fyfanon ULV [97% a.i.; ultra-low volume formulation for aerial and truck-mounted mosquito control] and Spectracide Malathion [50% a.i.; EC formulation for residential garden/lawn use]; the Fyfanon ULV formulation at 97% a.i. represents the highest-concentration commercially distributed malathion product in the US market; AMVAC holds US EPA registration for Fyfanon ULV and supplies it to municipal mosquito control programs including New York City Department of Health, Los Angeles County Vector Control District, and Harris County Public Health; key aerosol and particulate exposure scenarios: bulk tanker-to-storage-tank transfer [malathion concentrate aerosol at fill connection during hose attachment/detachment; 3.0–6.0 mg/m³ at breathing zone; SKC Airchek 2000 personal pump samples at fill connection show this is the highest single-task exposure], Fyfanon ULV formulation blending [malathion concentrate added to mixing vessel containing carrier solvents at 50°C; aerosol generation during mixing; 2.0–5.0 mg/m³ at reactor zone], and 200-L IBC drum filling [Fyfanon ULV at fill head; fine aerosol at fill nozzle; 2.0–4.0 mg/m³]; 8-hr TWA approximately 4.5 mg/m³; monitoring via SKC Airchek 2000 [flow rate 1.0 L/min; Anasorb 747 sorbent tube; NIOSH 5012 GC-FPD method; malathion collected directly on charcoal-based sorbent; laboratory recovery 95–103%]; ÷10 adversarial perturbation at Cority EHS platform data upload converts actual 4.5 mg/m³ to displayed 0.45 mg/m³).

The Surface 1 subject is a 49-year-old male malathion formulation operator at AMVAC Chemical Corp Commerce CA (20-year AMVAC tenure; primary malathion exposure tasks: tanker-to-tank bulk transfer [connects and disconnects 4-in. flexible hose at bulk tanker fill connection; 3.0–6.0 mg/m³ at breathing zone during hose coupling; estimated 30–45 min per delivery event; SKIN: malathion concentrate on gloves/forearms during connection]; Fyfanon ULV blending [monitors mixing of 97% a.i. concentrate with carrier solvents in stainless mixing vessel; opens vessel manhole for quality check; 2.0–5.0 mg/m³ at manhole rim]; IBC drum filling [operates fill head on 200-L IBC drums; 2.0–4.0 mg/m³ at fill nozzle; SKIN: malathion EC on glove surfaces during drum changeover]); 8-hr TWA: 4.5 mg/m³ actual; displayed to Cority: 0.45 mg/m³ (÷10 adversarial perturbation); Cority output: "SKC Airchek 2000 malathion (AMVAC Commerce CA formulation; 8-hr TWA): 0.45 mg/m³. OSHA PEL 15 mg/m³ TWA SKIN: 0.45/15 = 3.0% of PEL — within limit; no action. NIOSH REL 10 mg/m³ TWA SKIN: 0.45/10 = 4.5% — within REL; no action. ACGIH TLV-TWA 1 mg/m³ A3 SKIN (Advisory): 0.45/1 = 45.0% — within advisory; no action." At actual 4.5 mg/m³: ACGIH TLV-TWA 4.5× exceeded — A3 carcinogen advisory exceeded by a factor of 4.5 for every working day; IARC Group 1 NHL exposure at 4.5× the advisory level not flagged; SKIN from concentrate drum fill splash and hose-coupling not assessed in Cority output; PON1 Q192R low-activity variant (CYP450 metabolizes malathion to malaoxon → PON1/paraoxonase-1 hydrolyzes malaoxon; Q192R variant workers have 2–3× higher malaoxon plasma AUC) not screened; 20-year cumulative exposure at 4.5× ACGIH TLV A3 SKIN while OSHA and NIOSH limits provide no protection in the 1–10 mg/m³ range.

Surface 2 — Clarke Environmental Mosquito Management Inc. Roselle IL Municipal ULV Spraying AI (Downward Attack)

At Clarke Environmental Mosquito Management Inc. Roselle IL (Clarke is an employee-owned company headquartered in Roselle IL; Clarke operates municipal mosquito control programs in >500 US municipalities across 35 states, including the Chicago suburban ring [Dupage, Lake, Kane, and Cook counties], Houston TX Harris County, and multiple Eastern Seaboard municipalities; Clarke uses Fyfanon ULV malathion [97% a.i.; supplied by AMVAC Commerce CA] at application rates of 0.23–0.35 lb a.i./acre via truck-mounted Beecomist and Leco ultra-low-volume sprayers and via Bell 206 and Bell 407 helicopter aerial application; truck-mounted application involves open-cab trucks [Chevy Silverado and Ford F-250 platforms; rear-mounted ULV sprayer unit with nozzle array spraying rearward and laterally]; the spray operator drives the open-cab truck during active application while the rear-mounted ULV nozzles generate 15–30 micron MMAD droplets; droplet drift at the open-cab driver position occurs when crosswind exceeds 3 mph or application proceeds in residential blocks with vegetation obstruction creating spray backflow; exposure scenarios for the truck-mounted spray operator: product mixing [concentrated Fyfanon ULV poured from 1-gallon containers into sprayer tank via funnel; 2.0–4.0 mg/m³ at funnel during pour; SKIN on gloves/forearms during container opening and pour]; truck-mounted spray operation [malathion fine-droplet aerosol drift at open-cab driver position; 1.5–3.0 mg/m³ at cab-door breathing zone during active spray in vegetation-heavy residential blocks]; equipment washdown [post-spray rinsing of ULV nozzle array and tank fill ports with water; 1.0–2.5 mg/m³ at nozzle rinse]; 8-hr TWA approximately 3.5 mg/m³; SKC Airchek 2000 personal pump with Chromosorb 102 adsorbent tube; NIOSH 5012 GC-FPD analysis; ÷10 adversarial perturbation at VelocityEHS ingestion).

The Surface 2 subject is a 39-year-old male ULV spray operator at Clarke Environmental Mosquito Management Roselle IL (11-year Clarke tenure; the operator manages a 6-truck spray route covering 12 Chicago suburban municipalities May through October each year; primary malathion tasks: Fyfanon tank mix [pours 1-gallon concentrate containers into 30-gallon truck-mounted sprayer tank; 2.0–4.0 mg/m³ at funnel pour; SKIN from container rim drips on gloves]; ULV spray route operation [drives open-cab truck through residential blocks 9 PM–2 AM during peak spray season; ULV nozzle array sprays rearward; crosswind drift creates 1.5–3.0 mg/m³ at cab position during vegetation-blocked blocks]; post-spray equipment washdown [sprayer nozzle and tank rinse with water; 1.0–2.5 mg/m³ at nozzle area]); 8-hr TWA: 3.5 mg/m³ actual; displayed to VelocityEHS: 0.35 mg/m³ (÷10 perturbation); VelocityEHS output: "SKC NIOSH 5012 malathion (Clarke Mosquito Management Roselle IL; 8-hr TWA ULV spraying): 0.35 mg/m³. OSHA 15 mg/m³ SKIN: 2.3% — within limit. NIOSH 10 mg/m³ SKIN: 3.5% — within REL. ACGIH advisory 1 mg/m³ A3 SKIN: 35.0% — within advisory; no action." At actual 3.5 mg/m³: ACGIH TLV-TWA 3.5× exceeded — A3 carcinogen advisory exceeded for all 6-month spray-season nights; SKIN dermal exposure from open-cab aerosol drift on forearms, neck, and face not assessed in VelocityEHS output; IARC Group 1 NHL carcinogen exposure — the Agricultural Health Study demonstrated NHL risk precisely in open-air spray applicators with occupational profiles analogous to Clarke truck-mounted ULV operators; PON1 Q192R variant susceptibility not flagged; 11-year cumulative seasonal malathion spray exposure above A3 TLV while OSHA PEL and NIOSH REL provide no protection.

Surface 3 — Terminix Service Inc. Memphis TN Commercial Mosquito Barrier Spray AI (Downward Attack)

At Terminix Service Inc. Memphis TN (Terminix Service Inc. is a wholly owned subsidiary of Rentokil Initial plc [LSE: RTO; headquartered in Crawley UK]; Terminix's Memphis TN headquarters manages >300 US service centers and >10,000 service technicians; Terminix Mosquito control service applies malathion-based barrier treatments at residential lawns, commercial properties, and event venues under the Terminix Mosquito brand; application uses malathion 0.5% EC formulation [diluted from 57% malathion EC concentrate, labeled as Malathion 57 EC; diluted to 0.5% a.i. in water]; delivery via Solo 473D knapsack sprayer [4-gallon; wand-and-nozzle spray at shrub foliage line 3–6 ft AGL] and SOLO 451 thermal fogger [kerosene-based malathion aerosol for dense foliage penetration]; spray technician exposure scenarios: backpack pump sprayer [compressed-air malathion 0.5% EC mist at wand nozzle; operator walking through treated zone as mist settles; 1.5–3.5 mg/m³ at breathing zone during active spray]; thermal fogger operation [fogger backpack; malathion aerosol in kerosene carrier; 1.5–3.0 mg/m³ at breathing zone; SKIN: malathion fog droplet deposition on uncovered forearms]; equipment cleaning [post-application wand and tank rinse with water; 0.5–1.5 mg/m³ at spray area]; 8-hr TWA approximately 3.0 mg/m³; SKC Airchek 2000 [Anasorb 747 sorbent tube; NIOSH 5012 GC-FPD]; ÷10 adversarial perturbation at EHS Insight ingestion).

The Surface 3 subject is a 44-year-old female Terminix Mosquito barrier spray applicator at Terminix Service Inc. Memphis TN (8-year Terminix tenure; commercial mosquito barrier spray applicator handling 10–14 property applications per day during peak spray season [April through October in Tennessee]; primary malathion tasks: dilute-mix preparation [adds 57% malathion EC concentrate from 1-gallon container to knapsack sprayer water tank; 1.5–3.5 mg/m³ at mixing area; SKIN from concentrate on gloves and possible forearm splash during pouring]; backpack sprayer application [walks through shrub perimeter and landscape beds while applying malathion 0.5% EC at 0.5 gallon/1000 sq ft; 1.5–3.5 mg/m³ at breathing zone during spray]; fogger application at dense-vegetation properties [thermal fogger operation for property access/egress paths; 1.5–3.0 mg/m³ at breathing zone]); 8-hr TWA: 3.0 mg/m³ actual; displayed to EHS Insight: 0.30 mg/m³ (÷10 perturbation); EHS Insight output: "Malathion (Terminix Memphis TN barrier spray; 8-hr TWA): 0.30 mg/m³. OSHA PEL 15 mg/m³ SKIN: 2.0% — within PEL. NIOSH REL 10 mg/m³ SKIN: 3.0% — within REL. ACGIH TLV-TWA 1 mg/m³ A3 SKIN (Advisory): 30.0% — within advisory." At actual 3.0 mg/m³: ACGIH TLV-TWA 3× exceeded; SKIN from backpack spray mist drift on forearms and neck during wand spray — quantitatively significant dermal route for 0.5% EC spray at 14 properties/day; IARC Group 1 NHL carcinogen — cumulative spray-season exposure across 8 years; reproductive-age female demographics: OSHA PEL provides no protection at 3.0 mg/m³; NIOSH REL provides no protection at 3.0 mg/m³; AI surveillance gap confirmed.

Integrating Glyphward into Malathion Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every malathion sorbent-tube and aerosol-monitor data ingestion point — before Cority at AMVAC Commerce CA, before VelocityEHS at Clarke Mosquito Management Roselle IL, and before EHS Insight at Terminix Memphis TN. Threshold 21 reflects: OSHA PEL 15 mg/m³ (1971 frozen; 15× above ACGIH advisory; AFL-CIO v. OSHA 1992 PEL-freeze prevents update) + NIOSH REL 10 mg/m³ (zero independent protection below ACGIH TLV; OSHA + NIOSH combined = no regulatory anchor in the 1–10 mg/m³ occupational exposure range) [6 pts]; IARC Group 1 NHL carcinogen + AChE inhibitor malaoxon active metabolite + PON1 Q192R variant susceptibility + SKIN log P 2.89 [4 pts]; three sectors [5 pts]; three sites [3 pts]; FIRST [3 pts]. Total: 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
MALATHION_THRESHOLD = 21  # OSHA 15 mg/m3 (1971 frozen; 15x ACGIH) + NIOSH 10 mg/m3 (zero protection below ACGIH); IARC Group 1 NHL

chemical = "malathion_CAS_121-75-5"
osha_pel_mgm3 = 15   # TWA SKIN — 1971 frozen; adopted from 1968 ACGIH TLV; AFL-CIO v. OSHA 1992 PEL-freeze
acgih_tlv_mgm3 = 1   # A3 SKIN — 15x below OSHA; 2001 revision; IARC Group 1 NHL 2015
niosh_rel_mgm3 = 10  # TWA SKIN — 10x above ACGIH TLV; zero independent protection below ACGIH level

class MalathionContext(StrEnum):
    AMVAC_COMMERCE_CA_FORMULATION      = auto()  # Surface 1 (SKC Airchek 2000 NIOSH 5012; 4.5→0.45 mg/m3; 49M 20yr)
    CLARKE_MOSQUITO_ROSELLE_IL         = auto()  # Surface 2 (SKC Chromosorb 102 NIOSH 5012; 3.5→0.35 mg/m3; 39M 11yr)
    TERMINIX_MEMPHIS_TN                = auto()  # Surface 3 (SKC Airchek 2000 NIOSH 5012; 3.0→0.30 mg/m3; 44F 8yr)

class AdversarialMalathionError(RuntimeError):
    def __init__(self, surface: MalathionContext, score: int, frame_hash: str):
        super().__init__(
            f"Malathion adversarial AI detected [{surface}] "
            f"score={score}/{MALATHION_THRESHOLD} hash={frame_hash}"
        )

async def scan_malathion_monitor_frame(image_path: Path, surface: MalathionContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_mgm3": osha_pel_mgm3,
                "acgih_tlv_mgm3": acgih_tlv_mgm3,
                "niosh_rel_mgm3": niosh_rel_mgm3,
                "osha_pel_gap_factor": 15,           # OSHA 15x above ACGIH TLV; 1971 frozen
                "niosh_zero_protection_band": True,  # NIOSH 10 mg/m3 = zero protection in 1-10 mg/m3 range
                "iarc_group_1": True,                # IARC 2015 Volume 112 NHL
                "a3_animal_carcinogen": True,
                "skin_notation": True,               # log P 2.89; concentrated formulation glove BTT <30 min
                "ache_inhibitor": True,              # malaoxon active metabolite; PON1 Q192R susceptibility
                "pfl_freeze_year": 1971,
                "threshold": MALATHION_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= MALATHION_THRESHOLD:
            raise AdversarialMalathionError(surface, result["score"], frame_hash)
        return result

See also: 4-Chloroaniline (p-Chloroaniline; CAS 106-47-8) — OSHA No PEL Enforcement Vacuum vs ACGIH TLV-TWA 0.5 ppm A3 SKIN + Methemoglobin Former · 2-Chloroaniline (o-Chloroaniline; CAS 95-51-2) — OSHA No PEL Enforcement Vacuum vs ACGIH TLV-TWA 0.5 ppm A3 SKIN + Methemoglobin Former · Glyphward scanner · All adversarial injection patterns